As of June 30, 2025, NOS Nova AS carries a market capitalization of 2.17M, placing it among publicly traded companies globally. Its enterprise value stands at -143,868.14, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.17M |
| Enterprise Value | -143,868.14 |
As of June 30, 2025, NOS Nova AS has 22.33M shares outstanding.
| Shares Outstanding | 22.33M |
These figures are as of June 30, 2025.
| PB Ratio | 0.73 |
| P/TBV Ratio | 0.92 |
As of June 30, 2025, NOS Nova AS maintains a current ratio of 5.28, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.28 |
| Quick Ratio | 4.36 |
| Debt / Equity | 1.86 |
These figures cover the twelve months ended June 30, 2025.
| Employee Count | 35.00 |
As of the close on November 17, 2026, NOS Nova AS's stock has declined approximately 8.33% over the past 52 weeks. The 50-day moving average sits at 0.10, while the 200-day moving average is 0.11.
| 52-Week Price Change | -8.33% |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | 0.11 |
As of June 30, 2025, NOS Nova AS holds 2.37M in cash and equivalents against 55,147.95 in total debt, resulting in a net debt position of -2.37M. Total book value stands at 2.97M, with working capital of 2.33M providing operational flexibility.
| Cash & Cash Equivalents | 2.37M |
| Total Debt | 55,147.95 |
| Net Debt | -2.37M |
| Equity (Book Value) | 2.97M |
| Book Value Per Share | 0.13 |
| Working Capital | 2.33M |
These figures cover the twelve months ended June 30, 2025.
| Capital Expenditures | -387,566.03 |
Already premium?